Aadi Bioscience (NASDAQ:AADI) Given New $33.00 Price Target at LADENBURG THALM/SH SH

Aadi Bioscience (NASDAQ:AADI – Get Rating) had its price target lowered by LADENBURG THALM/SH SH from $47.00 to $33.00 in a research report sent to investors on Thursday morning, The Fly reports. Separately, HC Wainwright reduced their price objective on shares of Aadi Bioscience from $48.00 to $45.00 and set a buy rating for the […]

Related Keywords

Aadi Bioscience ,Neil Desai ,Los Angeles ,Ghost Tree Capital ,Aadi Bioscience Inc ,Aadi Bioscience Company Profile ,Group Plc ,Jump Financial ,Get Rating ,Chairman Neil Desai ,Tree Capital ,General Group Plc ,Aadi Bioscience Daily ,Nasdaq Aadi ,Maadi ,Medical ,Lower Price Target ,Ladenburg Thalm Sh ,